Australian Vaccinology Course 202619–21 October 2026 | Q Station – Sydney, AustraliaBoost your impact in immunisationA member of the International Collaboration on Advanced Vaccinology Training (ICAVT) Thank you for joining the Australian Vaccinology Course 2026! Session presentations Day 1WelcomeProfessor Nicholas WoodVaccination in 2026Professor Kristine MacartneyHow vaccines workProfessor Katie FlanaganVaccines from research to licensureProfessor Chris BlythDr Chris MorganProfessor Helen MarshallDecision making for vaccine policyProfessor Allen ChengDr Chris MorganMs Katrina ClarkIncreasing vaccine uptakeProfessor Julie LeaskDecision making for vaccine policy: case studyProfessor Allen Cheng / Professor Michelle Giles / Professor Katie Flanagan / Professor Julia Brotherton / Dr Chris MorganDay 1 summaryProfessor Nicholas WoodDay 2WelcomeProfessor Nicholas WoodMeasuring the impact of vaccinationProfessor Peter McIntyreProfessor Meru Sheel: Part A / Part BUsing linked data to measure vaccine effectiveness and impactProfessor Bette LiuConsiderations for vaccination programs and introducing new vaccines: vaccination in pregnancyProfessor Michelle GilesConsiderations for vaccination programs and introducing new vaccines: vaccination for adolescentsProfessor Julia BrothertonProfessor Helen MarshallConsiderations for vaccination programs and introducing new vaccines: vaccination for older adultsProfessor Katie FlanaganConsiderations for vaccination programs and introducing new vaccines: vaccination for Aboriginal and Torres Strait Islander peopleMs Katrina ClarkConsiderations for vaccination programs and introducing new vaccines: low- and middle-income settingsDr Chris MorganMeasuring the impact of vaccination: case studyAssociate Professor Aditi Dey / Ms Katrina ClarkSpecial lecture: disease eradication and waning vaccine immunityProfessor Peter McIntyreDay 2 summaryProfessor Nicholas WoodDay 3WelcomeProfessor Nicholas WoodVaccine safetyProfessor Michael GoldProfessor Kristine MacartneyPrinciples of vaccine risk communicationProfessor Julie LeaskVaccine safety and vaccine risk communication: case studyProfessor Julie LeaskNew and emerging topics in vaccinationProfessor Meru SheelProfessor Allen ChengProfessor Peter McIntyreProfessor Katie FlanaganProfessor Helen MarshallProfessor Kristine MacartneyClosing remarksProfessor Nicholas Wood Program View full course program Presenters Professor Kristine Macartney Director, NCIRS Professor Nicholas Wood Associate Director, Clinical Research and Services, NCIRSProfessor Peter McIntyre Head, Department of Paediatrics and Child Health, University of OtagoProfessor Chris Blyth Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases Professor Allen Cheng Director, Infectious Diseases, Monash HealthMs Katrina Clark Aboriginal Immunisation Manager, Health Protection, Population Health, Hunter New England Local Health DistrictProfessor Katie Flanagan Senior Staff Specialist, Westmead Hospital Professor Julie Leask AO Professor and Social Scientist, Faculty of Medicine and Health, University of Sydney Professor Julia BrothertonProfessor of Cancer Prevention Policy and Implementation, The University of MelbourneAssociate Professor Aditi DeySenior Research Fellow/Manager, Surveillance, NCIRSProfessor Michelle Giles Lead Clinical and Health Systems Research, The Peter Doherty Institute for Infection and Immunity Professor Michael GoldProfessor, Faculty of Health and Medical Sciences, The University of Adelaide Professor Paul Kelly PK Public Health AdvisoryHonorary Professor Australian National University College of Law, Governance and PolicyProfessor Bette LiuAssociate Director, Population Health, NCIRSProfessor Helen MarshallConsultant and Professor in Vaccinology, The University of AdelaideProfessor Meru Sheel Professor of Infectious Diseases and Global Health, Faculty of Medicine and Health, University of Sydney Learning outcomes By the end of this course, participants should be able to: describe how vaccines create immunity in patients across the life span outline the process of vaccine development, from research to licensure, in low-, middle- and high-income settingsdescribe evidence-based approaches to vaccination program decision-making processes in low-, middle- and high- income settingscritique the main explanatory models and frameworks used to explain low vaccination coveragemeasure the impact of vaccination on disease burden and vaccine effectiveness using surveillance data and coverage assessmentsmeasure vaccination coverage and impact in priority populationsunderstand the principles of using linked data to measure vaccine effectiveness and impactdescribe vaccine characteristics, program recommendations and conversation approaches for specific population groupsdescribe strategies that support equitable immunisation outcomes for Aboriginal and Torres Strait Islander people, including culturally safe practice, community engagement, improved access, and increased vaccination uptakedescribe key considerations for prioritising and introducing new vaccines in low- and middle-income settingsexplain the principles of vaccine safety, including reporting of adverse events following immunisation apply the principles of public risk communication to a vaccine safety issueapply evidence on the strategies that increase uptake in a real-world scenariodescribe new and emerging topics in vaccination. Enquiries Please email SCHN-NCIRS-AVC@health.nsw.gov.au 191 views